Literature DB >> 21549102

Rad GTPase induces cardiomyocyte apoptosis through the activation of p38 mitogen-activated protein kinase.

Zhongcui Sun1, Ji Zhang, Jifeng Zhang, Chunlei Chen, Quan Du, Lin Chang, Chunmei Cao, Ming Zheng, Minerva T Garcia-Barrio, Yuqing E Chen, Rui-Ping Xiao, Jieming Mao, Xiaojun Zhu.   

Abstract

Rad is a member of a subclass of small GTP-binding proteins, the RGK family. In the present study we investigated the role of Rad protein in regulating cardiomyocyte viability. DNA fragmentation and TUNEL assays demonstrated that Rad promoted rat neonatal cardiomyocyte apoptosis. Rad silencing fully blocked serum deprivation induced apoptosis, indicating Rad is necessary for trigger cardiomyocyte apoptosis. Rad overexpression caused a dramatic decrease of the anti-apoptotic molecule Bcl-x(L), whereas Bcl-x(L) overexpression protected cardiomyocytes against Rad-induced apoptosis. Rad-triggered apoptosis was mediated by the activation of p38 MAPK. The p38 blocker SB203580 effectively protected cardiomyocytes against Rad-evoked apoptosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549102     DOI: 10.1016/j.bbrc.2011.04.104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Comparative transcriptomics of limb regeneration: Identification of conserved expression changes among three species of Ambystoma.

Authors:  Varun B Dwaraka; Jeramiah J Smith; M Ryan Woodcock; S Randal Voss
Journal:  Genomics       Date:  2018-08-06       Impact factor: 5.736

Review 2.  Regulation of voltage-dependent calcium channels by RGK proteins.

Authors:  Tingting Yang; Henry M Colecraft
Journal:  Biochim Biophys Acta       Date:  2012-10-10

3.  Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes.

Authors:  Theocharis Panaretakis
Journal:  Cell Cycle       Date:  2012-09-14       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.